Trials / Completed
CompletedNCT00741858
Duragen Versus Duraguard in Chiari Surgery
Prospective Randomized Study of Duragen vs. Duraguard in Chiari Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates two materials used for duraplasty of the posterior cranial fossa in treatment of Chiari malformation. One material (DuraGen) is a non-suturable collagen matrix that is applied over the defect if brain coverings (dura); the other (DuraGuard) is made out of bovine pericardium and has to be sutured during application. The study compares these two materials used for duraplasty of patients undergoing Chiari surgery in a prospective randomized fashion to check the rate of surgical complications associated with each material, patient's outcomes, length of surgery and the hospital stay, etc.
Detailed description
The study is aimed at comparative analysis of two frequently used duraplasty materials: one is made out of bovine pericardium, and the other - from bovine collagen derived from bovine achilles tendon. Both materials are routinely used form this intervention (duraplasty), but the question of superiority of one over the other remains open. This study follows patients with Chiari malformation from the time of surgery to the time of their discharge from the hospital and then another 3 months of follow up care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Duragen duraplasty | Posterior cranial fossa repair and enlargement with application of dural patch (Duragen) |
| PROCEDURE | Duraguard duraplasty | Posterior cranial fossa repair and enlargement with application of dural patch (Duraguard) |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2009-12-01
- Completion
- 2010-04-01
- First posted
- 2008-08-26
- Last updated
- 2015-07-13
- Results posted
- 2015-07-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00741858. Inclusion in this directory is not an endorsement.